Canada markets closed

Perspective Therapeutics, Inc. (CATX)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.6000+0.0700 (+4.58%)
At close: 04:00PM EDT
1.5999 -0.00 (-0.01%)
After hours: 07:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 996.21M
Enterprise Value 818.44M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.33
Enterprise Value/Revenue 68.73
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 3213.73%
S&P500 52-Week Change 326.49%
52 Week High 31.9100
52 Week Low 30.2100
50-Day Moving Average 31.4658
200-Day Moving Average 30.7068

Share Statistics

Avg Vol (3 month) 35.12M
Avg Vol (10 day) 36.96M
Shares Outstanding 5622.63M
Implied Shares Outstanding 6622.63M
Float 8354.17M
% Held by Insiders 123.42%
% Held by Institutions 145.20%
Shares Short (Apr 30, 2024) 413.59M
Short Ratio (Apr 30, 2024) 42.13
Short % of Float (Apr 30, 2024) 42.91%
Short % of Shares Outstanding (Apr 30, 2024) 42.32%
Shares Short (prior month Mar 28, 2024) 48.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,855.02%

Management Effectiveness

Return on Assets (ttm)-32.81%
Return on Equity (ttm)-57.70%

Income Statement

Revenue (ttm)1.43M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -39.96M
Net Income Avi to Common (ttm)-37.45M
Diluted EPS (ttm)-0.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.24M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)2.55M
Total Debt/Equity (mrq)3.39%
Current Ratio (mrq)1.08
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-36.91M
Levered Free Cash Flow (ttm)-8.27M